Psychedelics
The convertible debentures will raise up to half a billion
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "Cybin Inc."
Psychedelics
It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety
Psychedelics
The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio
Canada
Cybin will pay Mindset an initial US$500K and 'development milestone payments' that could potentially total US$9.5M afterward
Canada
First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company
Cannabis
New license is the final required step before administering doses to study participants
Alternative Energy
Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly
